Revance Therapeutics Inc (RVNC)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Revance Therapeutics Inc (RVNC) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011463
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Revance Therapeutics Inc (Revance Therapeutics) develops, manufactures and commercializes novel botulinum toxin products. The company’s product candidate includes RT002, an injectable formulation of botulinum toxin type for the treatment of glabellar lines, cervical dystonia, and plantar fasciitis among others. It also provides RT001, a topical gel formulation of daxibotulinumtoxinA, which is designed to eliminate the use of needles. Revance Therapeutics develops products for multiple aesthetic and therapeutic applications. The company utilizes TransMTS platform technology for the development of its products. It offers products for dermatology, neurology, musculoskeletal disorders, urology and ophthalmology. Revance Therapeutics is headquartered in Newark, California, the US.

Revance Therapeutics Inc (RVNC) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Revance Therapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Revance Therapeutics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Revance Therapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Revance Therapeutics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Revance Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Revance Therapeutics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Revance Therapeutics Raises US$10 Million In Venture Financing 10
Revance Therapeutics Raises US$56 Million In Extended Series E Financing 11
Revance Therapeutics Secures US$40 Million In Venture Financing 13
ReVance Therapeutics Secures US$5 Million In Financing Round 14
Equity Offering 15
Revance Therapeutics Raises USD167.1 Million in Public Offering of Shares 15
Revance Therapeutics Raises USD134.6 Public Offering of Shares 17
Revance Therapeutics Completes IPO For US$110.4 Million 19
Revance Therapeutics Inc – Key Competitors 21
Revance Therapeutics Inc – Key Employees 22
Revance Therapeutics Inc – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Financial Announcements 24
Aug 03, 2017: Revance Releases Second Quarter 2017 Results 24
May 09, 2017: Revance Releases First Quarter 2017 Results 25
Feb 27, 2017: Revance Releases Fourth Quarter and Full Year 2016 Results 26
Nov 03, 2016: Revance Releases Third Quarter 2016 Results 28
Aug 04, 2016: Revance Releases Second Quarter 2016 Results 29
May 09, 2016: Revance Releases First Quarter 2016 Results 30
Mar 02, 2016: Revance Releases Fourth Quarter and Full Year 2015 Results 31
Corporate Communications 32
Sep 06, 2017: Revance Appoints Mark Foley to its Board of Directors 32
Aug 02, 2017: Revance appoints new chief commercial officer and president of Aesthetics & Therapeutics 33
Jul 05, 2016: Revance Appoints Industry Leader Julian S. Gangolli to its Board of Directors 34
Mar 14, 2016: Revance Therapeutics Expands Leadership Team, Appoints Roman G. Rubio, MD, MBA, as Senior Vice President of Clinical Development 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Revance Therapeutics Inc, Medical Equipment, Key Facts, 2016 2
Revance Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Revance Therapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Revance Therapeutics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Revance Therapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Revance Therapeutics Inc, Deals By Market, 2011 to YTD 2017 8
Revance Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Revance Therapeutics Raises US$10 Million In Venture Financing 10
Revance Therapeutics Raises US$56 Million In Extended Series E Financing 11
Revance Therapeutics Secures US$40 Million In Venture Financing 13
ReVance Therapeutics Secures US$5 Million In Financing Round 14
Revance Therapeutics Raises USD167.1 Million in Public Offering of Shares 15
Revance Therapeutics Raises USD134.6 Public Offering of Shares 17
Revance Therapeutics Completes IPO For US$110.4 Million 19
Revance Therapeutics Inc, Key Competitors 21
Revance Therapeutics Inc, Key Employees 22
Revance Therapeutics Inc, Subsidiaries 23

★海外企業調査レポート[Revance Therapeutics Inc (RVNC)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Republic Services Inc (RSG):企業の財務・戦略的SWOT分析
    Republic Services Inc (RSG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Kbc Bank Ireland Plc:企業の戦略・SWOT・財務分析
    Kbc Bank Ireland Plc - Strategy, SWOT and Corporate Finance Report Summary Kbc Bank Ireland Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Lee Enterprises Inc (LEE):企業の財務・戦略的SWOT分析
    Lee Enterprises Inc (LEE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Theravasc Inc-製薬・医療分野:企業M&A・提携分析
    Summary Theravasc Inc (Theravasc) is a healthcare services provider that develops treatments for various chronic medical diseases using oral formulation of sodium nitrite. The company’s product TV1001SR is a coated oral formulation of sodium nitrite for the treatment of peripheral artery diseases an …
  • Coppermoly Limited:企業の戦略・SWOT・財務情報
    Coppermoly Limited - Strategy, SWOT and Corporate Finance Report Summary Coppermoly Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Noble Energy Inc (NBL)-石油・ガス分野:企業M&A・提携分析
    Summary Noble Energy, Inc. (Noble Energy) is an independent energy company that explores for and produces crude oil, natural gas and natural gas liquids (NGLs). The company’s portfolio includes both US unconventional and global offshore conventional assets in various countries. Noble Energy has oper …
  • Intra-Cellular Therapies Inc (ITCI):企業の財務・戦略的SWOT分析
    Summary Intra-Cellular Therapies Inc (ICTI) is a biopharmaceutical company. The company develops drugs for the treatment of neuropsychiatric and neurodegenerative diseases. Its pipeline products include lumateperone (ITI-007), used for the treatment of schizophrenia, behavioral disturbances associat …
  • Omega Pharma NV:企業の戦略・SWOT・財務情報
    Omega Pharma NV - Strategy, SWOT and Corporate Finance Report Summary Omega Pharma NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Faron Pharmaceuticals Oy (FARN)-製薬・医療分野:企業M&A・提携分析
    Summary Faron Pharmaceuticals Oy (Faron Pharma) is a drug company that carries out clinical stage drug discovery and development. The company's product portfolio includes traumakine; clevegen; farbetic, an AOC3 inhibitor and D-ARDS, a diagnostic tool. Its traumakine clinical programme manages the tr …
  • Wheelock and Company Limited :企業の戦略・SWOT・財務情報
    Wheelock and Company Limited - Strategy, SWOT and Corporate Finance Report Summary Wheelock and Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Parkway Pantai Ltd:企業の戦略的SWOT分析
    Parkway Pantai Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Summit Therapeutics Plc (SUMM):製薬・医療:M&Aディール及び事業提携情報
    Summary Summit Therapeutics Plc (Summit), formerly Summit Corp Plc is a clinical-stage drug discovery and development company that offer therapies. The company conducts research and development on the treatment of rare diseases and infectious diseases including duchenne muscular dystrophy and the in …
  • Olmsted Medical Center:製薬・医療:M&Aディール及び事業提携情報
    Summary Olmsted Medical Center (OMC) is a healthcare service provider that offers patient care services. The center offers services in the areas of general surgery, podiatry, pain management, dermatology, plastic surgery, inpatient dietary services, pediatrics, diabetes education, neurology, psychia …
  • Genentech, Inc.:企業の戦略・SWOT・財務分析
    Genentech, Inc. - Strategy, SWOT and Corporate Finance Report Summary Genentech, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • BBVA Banco Frances S.A. (FRAN3):企業の財務・戦略的SWOT分析
    BBVA Banco Frances S.A. (FRAN3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • The Western Union Company:企業のM&A・事業提携・投資動向
    The Western Union Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Western Union Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Wood Group Mustang Inc-石油・ガス分野:企業M&A・提携分析
    Summary Wood Group Mustang, Inc. (Wood Group Mustang), a subsidiary of John Wood Group PLC is an engineering management company. It provides engineering, procurement, and construction management (EPC) services to clients across diverse end markets. The company’s service portfolio comprises design an …
  • ICA Gruppen AB:企業の戦略・SWOT・財務情報
    ICA Gruppen AB - Strategy, SWOT and Corporate Finance Report Summary ICA Gruppen AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Crexendo Inc (CXDO):企業の財務・戦略的SWOT分析
    Summary Crexendo Inc (Crexendo) is a technology company that offers critical voice and data technology infrastructure services. The company offers internet phones, colour internet phones, SIP phone, DTA phones and mobile applications. It offers cloud communication and network services. Crexendo’s ne …
  • Patterson-UTI Energy, Inc. (PTEN):石油・ガス:M&Aディール及び事業提携情報
    Summary Patterson-UTI Energy Inc (Patterson) is an oilfield service provider. It offers onshore contract drilling and pressure pumping services to oil and gas exploration and production companies. The company offers pressure pumping services such as well stimulation and cementing for completion of n …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆